Merck KGaAMKGAF has provided an update regarding the stages of development of its key immuno oncology and oncology pipeline candidates. The company also stated that it is working on accelerating high priority programs with a focus on securing long
Merck KGaA's Pipeline on Track, Updates Key R&D Projects
